Sanofi and Regeneron Pharmaceuticals recently published the results of the clinical trial for Dupixent, or Dupilumab, a treatment for children between ages 6 and 11 with moderate to severe uncontrolled […]
The post Black Children Not Prioritized In Asthma Drug Study, Despite Highest Fatality Rate appeared first on Essence.
